Personal tools

FF:0000361: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{F5terms
{{F5terms
|id=FF:0000361
|alt_id=
|name=4 hr
|namespace=FANTOM5
|def=
|xref=
|is_a=UO:0000032
|synonym=
|comment=
|comment=
|alt_id=
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def=
|subset=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=FF:0000361
|is_a=UO:0000032
|is_obsolete=
|located_in=
|located_in=
|name=4 hr sample
|namespace=FANTOM5
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=
|property_value=
|is_obsolete=
|subset=
|preceded_by=
|synonym=
|union_of=
|xref=
}}
}}

Latest revision as of 16:55, 12 September 2014

outline

  • id: FF:0000361
  • name: 4 hr sample
  • namespace: FANTOM5
  • CAGEd oPOSSUM: NA

Ontology association

Parents

is_a:UO:0000032(hour)

Children

is a:FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000509 (mouse J2E erythroblastic leukemia line 4hr after treatment with erythropoietin sample),FF:0000525 (human K562 erythroblastic leukemia line 4hr after treatment with hemin sample),FF:0000553 (human Aortic Smooth Muscle cells 4hr after treatment with FGF2 sample),FF:0000563 (human Aortic Smooth Muscle cells 4hr after treatment with IL1b sample),FF:0000577 (human Monocyte-derived macrophages 4h after LPS treatment sample),FF:0000603 (human Saos2 osteosarcoma cell line 4h after induction of calcification with ascorbate and BPG sample),FF:0000614 (mouse EBF KO HPCs induced to T cell 4h sample),FF:0000721 (Saos2 osteosarcoma cell line 4h untreated control),FF:0011233 (mouse tracheal ciliated cells differentiation after 4hr sample),FF:3568-170I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3578-170A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3588-170B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3598-170C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb),FF:3640-171I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3650-171A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3660-171B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3670-171C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb, 004hr, biol_rep2),FF:3705-172B1 (macrophage, TB infection, non-stimulated BMDM, without Mtb),FF:3971-173H4 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb)

FF Samples

Mouse

  • 3568-170I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph))
  • 3578-170A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb)
  • 3588-170B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb)
  • 3598-170C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb)
  • 3640-171I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph))
  • 3650-171A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb)
  • 3660-171B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb)
  • 3670-171C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb, 004hr, biol_rep2)
  • 3705-172B1 (macrophage, TB infection, non-stimulated BMDM, without Mtb)
  • 3971-173H4 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb)